Bart J. Verwer
Impact in
- Hepatology top 1%
- Liver Diseases and Immunity
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 12
- Liver Diseases and Immunity 11
- Hepatocellular Carcinoma Treatment and Prognosis 1
-
- Systemic Lupus Erythematosus Research 3
- Co-authors
- Chris J. Mulder (4 shared papers)Tim C. M. A. Schreuder (1 shared paper)Wilmar de Graaf (1 shared paper)Roel J. Bennink (1 shared paper)Th. M. van Gulik (1 shared paper)Dirk Joan Gouma (1 shared paper)Sander Dinant (1 shared paper)Arlène K. van Vliet (1 shared paper)
- Journals
- Journal of Hepatology (3 papers)Genes and Immunity (1 paper)Journal of Nuclear Medicine (1 paper)Trials (1 paper)BMC Cancer (1 paper)
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
Bart J. Verwer
15 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 53
- Hepatology 767
- Epidemiology 565
- Rheumatology 83
- Pharmacology 41
- Surgery 195
Countries citing papers authored by Bart J. Verwer
This map shows the geographic impact of Bart J. Verwer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart J. Verwer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart J. Verwer more than expected).
Fields of papers citing papers by Bart J. Verwer
This network shows the impact of papers produced by Bart J. Verwer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart J. Verwer. The network helps show where Bart J. Verwer may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart J. Verwer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 258 | |
| 2 | 2012 | 177 | |
| 3 | 2008 | 164 | |
| 4 | 2014 | 150 | |
| 5 | 2007 | 145 | |
| 6 | 2015 | 95 | |
| 7 | 2018 | 28 | |
| 8 | 2020 | 27 | |
| 9 | 2018 | 22 | |
| 10 | 2020 | 19 | |
| 11 | 2022 | 8 | |
| 12 | 2021 | 6 | |
| 13 | 2023 | 4 | |
| 14 | 2017 | 2 | |
| 15 | [Diagnosis and treatment of autoimmune hepatitis]. | 2009 | 1 |
| 16 | 2025 | 0 |
About Bart J. Verwer
Bart J. Verwer is a scholar working on Hepatology, Rheumatology, Epidemiology, Endocrinology, Diabetes and Metabolism and Cell Biology, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include Liver Diseases and Immunity (11 papers), Liver Disease Diagnosis and Treatment (5 papers), Systemic Lupus Erythematosus Research (3 papers), Diet, Metabolism, and Disease (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper) and Endoplasmic Reticulum Stress and Disease (1 paper). The work is most often cited by research in Hepatology (767 citations), Epidemiology (565 citations), Rheumatology (83 citations), Pharmacology (41 citations) and Surgery (195 citations). Bart J. Verwer has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Chris J. Mulder, Tim C. M. A. Schreuder, Wilmar de Graaf, Roel J. Bennink, Th. M. van Gulik, Dirk Joan Gouma, Sander Dinant, Arlène K. van Vliet, Krijn P. van Lienden and Gerd Bouma. Their work appears in journals such as Journal of Hepatology, Genes and Immunity, Journal of Nuclear Medicine, Trials and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.